UPRIGHT-PRO: Prospective Development Study of Upright Proton Therapy
Starting soon
Conditions studied: Proton Therapy
In brief
This study is being done to evaluate whether cancer patients can safely and reliably receive proton radiation therapy while positioned upright. Proton therapy is an established form of radiation treatment, and the upright treatment system used in this study has been cleared by the U.S. Food and Drug Administration. The intent of this protocol is to observe the treatment methods, doses, and outcomes for the initial cohorts of patients treated with this upright device. This study will support research activities and evaluate feasibility as needed. Results of this study will be reported in the scientific literature but the investigators do not intend to report to the FDA for a new use or indication or change to the labeling; nor are the investigators required to do so.
Key facts
- Study ID
- NCT07708636
- Run by
- Stanford University
- People needed
- 450
- Starts
- 2026-09-01
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-07-16
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Any cancer patient (children and adults) recommended for proton therapy.
- Participation in other clinical trials is allowed (including randomized trials of protons versus other treatments)
You may not qualify if…
- Any patient that doesn't meet the inclusion criteria
Where it is running
- Lucile Packard Children's Hospital Stanford — Palo Alto, California, United States
- Stanford University — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.